ARAY

Accuray Incorporated

ARAY, USA

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

https://www.accuray.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
ARAY
stock
ARAY

Accuray Incorporated $ARAY Stock Holdings Increased by Armistice Capital LLC Defense World

Read more →
ARAY
stock
ARAY

S P Trends: Will ARAY stock split attract more investors - Fed Meeting & Free Community Supported Trade Ideas moha.gov.vn

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$3.875

Analyst Picks

Strong Buy

3

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Medium

2.11

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-35.04 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-4.75 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Low

8.89 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

6.38

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 55.39% of the total shares of Accuray Incorporated

1.

TCW Group Inc

(10.5695%)

since

2025/06/30

2.

BlackRock Inc

(8.0244%)

since

2025/06/30

3.

Vanguard Group Inc

(4.7664%)

since

2025/06/30

4.

Neuberger Berman Group LLC

(4.6606%)

since

2025/06/30

5.

Heartland Advisors Inc

(4.4895%)

since

2025/06/30

6.

Armistice Capital, LLC

(2.8719%)

since

2025/06/30

7.

Renaissance Technologies Corp

(2.3114%)

since

2025/06/30

8.

Geode Capital Management, LLC

(2.1493%)

since

2025/06/30

9.

State Street Corp

(1.7696%)

since

2025/06/30

10.

Foundry Partners, LLC

(1.5936%)

since

2025/03/31

11.

D. E. Shaw & Co LP

(1.5916%)

since

2025/06/30

12.

UBS Group AG

(1.5809%)

since

2025/06/30

13.

Tenor Capital Management Co Lp

(1.3312%)

since

2025/06/30

14.

Harbert Fund Advisors Inc

(1.2858%)

since

2025/06/30

15.

Acuitas Investments, LLC

(1.2656%)

since

2025/06/30

16.

Dafna Capital Management LLC

(1.0848%)

since

2025/06/30

17.

North Star Investment Management Corp

(1.0586%)

since

2025/06/30

18.

Silverback Aset Management LLC

(1.0349%)

since

2025/06/30

19.

Mackenzie Investments

(0.9901%)

since

2025/06/30

20.

Kovack Advisors Inc

(0.9562%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(6)
Net Net
Possible Net-Net(3.5)
Quality
Low Quality Business(3)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.